Pathway Medical Raises $40 Million

Pathway Medical Technologies Inc., a Kirkland, Wash.-based developer of endovascular treatments for peripheral arterial disease, has raised $40 million in Series D funding. Return backers include HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Forbion Capital Partners and Giza Venture Capital.

North AmericaUSBriefs